Announcements Trials

Browse Landscape

Status

Recruiting 2 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Observation 23 Blood Specimen Collection 20 Drug Therapy 14 Surveys and Questionnaires 10 Surgical Procedures, Operative 8 Immune Checkpoint Inhibitors 8 Immunotherapy 7 Positron Emission Tomography Computed Tomography 5 Hematologic Tests 5 Watchful Waiting 4 Neoadjuvant Therapy 4 Fluorodeoxyglucose F18 4 Bevacizumab 4 tislelizumab 3 envafolimab 3 darolutamide 3 Tyrosine Kinase Inhibitors 3 Therapeutics 3 Standard of Care 3 Radiotherapy 3 Letrozole 3 Indocyanine Green 3 Imatinib Mesylate 3 Endosonography 3 Endoscopic Mucosal Resection 3 Docetaxel 3 Cyclophosphamide 3 Capecitabine 3 Artificial Intelligence 3 pertuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Observational × vorasidenib × Clear all

NCT06969352 2025-05-13

VICTORIA

Servier (Tianjin) Pharmaceutical Co. LTD.

Not yet recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡